Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 59
Filtrar
1.
Ann Pharm Fr ; 74(3): 198-204, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26826794

RESUMO

Cesium templated Staudinger-aza-Wittig tandem reaction (S.A.W.) has been used in the synthesis of a bis-diazacrown-bis-cellobiosyl-tetra-ureido cryptand. A novel macrotricyclic compound having a "cone-shaped" configuration was selectively obtained. Additionally, first results on potential recognition properties of the cryptand are also given.


Assuntos
Césio/química , Éteres Cíclicos/química , Compostos Policíclicos/química , Bases de Schiff/química , Tartaratos/química , Compostos Aza/química , Cátions/química , Coronantes/química , Modelos Moleculares , Conformação Molecular
2.
Rev Med Suisse ; 11(456-457): 129-32, 134, 2015 Jan 14.
Artigo em Francês | MEDLINE | ID: mdl-25799669

RESUMO

In 2014, among new therapeutic approaches in pulmonary medicine, the role of inhaled corticosteroids has to be revaluated after the publication of the WISDOM and other studies. Their prescription should no longer be systematic even for "at risk" groups of patients, as defined by the GOLD consensus, but rather be considered on an individual basis. In the field of asthma, two major studies confirm the efficacy of mepoluzimab for the treatment of severe, eosinophilic asthma. Finally, for idiopathic pulmonary fibrosis, 2014 has taught us that treatment with N-acetylcystein is of no proven benefit, while pirfenidone and nintedanib are two new drugs that may attenuate the downhill course of the disease.


Assuntos
Asma/tratamento farmacológico , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Fibrose Pulmonar/tratamento farmacológico , Corticosteroides/uso terapêutico , Anticorpos Monoclonais Humanizados/uso terapêutico , Humanos , Índice de Gravidade de Doença
3.
Ann Pharm Fr ; 72(6): 422-8, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25438653

RESUMO

An intramolecularly promoted SAW reaction between a phosphinimide and an isocyanate intermediate led to an original bridged trisubstituted ((A,C),E)-α-cyclodextrin. The latter was in a second step converted into a new capped (ACE)-(guanidino)-α-cyclodextrin.


Assuntos
Guanidina/química , alfa-Ciclodextrinas/química , Hidrocarbonetos Aromáticos com Pontes/síntese química , Hidrocarbonetos Aromáticos com Pontes/química , Dióxido de Carbono/química , Indicadores e Reagentes , Modelos Moleculares
4.
Rev Med Suisse ; 9(369): 142-6, 2013 Jan 16.
Artigo em Francês | MEDLINE | ID: mdl-23409656

RESUMO

This review reports on papers published in 2012 that will most likely impact on daily medical practice in four different areas of pulmonary medicine. How should treatment of asthma with inhaled corticosteroids be adjusted on the long run? Should idiopathic pulmonary fibrosis receive treatment with immunosuppressive drugs? Is a long-term treatment with azithromycine for bronchiectasis supported by evidence, apart from patients with cystic fibrosis? And finally, can treatment of obstructive sleep apnea with continuous positive pressure (CPAP) prevent the occurrence of new, systemic hypertension?


Assuntos
Pneumologia/tendências , Clínicos Gerais , Humanos
5.
Ann Pharm Fr ; 70(6): 360-9, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23177563

RESUMO

Cyclodextrins (CyDs) currently displays even today the image of a natural macrocyclic compound largely dominant in the formation of inclusion complexes with small hydrophobic molecules. During the past 10years, advances in this field allowed to achieve more and more sophisticated CyDs derivatives opening a simple access in scale-up quantities to original and better CyD-based gene delivery systems. In addition, possibility to combine covalent and supramolecular approaches offers new venues for the design of tailor-made CyD-based nanovehicles to improve their transfection ability and gene transfer in cells. In this account, we describe our recent progress in the construction of a novel CyD-based G0 (generation number) core dendrimer, scalable to CyD oligomers by a strategy using protonable guanidine tethers and whose concept can be generalized for the assembly of CyD pre-coated dendrimers. The synthetic strategy based on an original Staudinger-Aza-Wittig tandem coupling reaction. We present an outline of the different analytical strategies to characterize CyD-ODN (cyclodextrin-oligodeoxynucleotide) complexes. Among them, Capillary electrophoresis (CE) was used to perfectly characterize our CyD-siRNA and CyD-DNA complexes and shown to be a very attractive method with advantages of low sample consumption, rapid analysis speed, and high efficiency that make this technology a major tool for association constant measurement. Finally, we present the different biological methods that can be used, in vitro, to study gene delivery, and more precisely ones we have performed to evaluate the capability of our original model bis-guanidinium-tetrakis-ß-cyclodextrin dendrimeric tetrapod, to deliver efficiently DNA or siRNA in eukaryotic cells.


Assuntos
Ciclodextrinas/química , Portadores de Fármacos/química , Técnicas de Transferência de Genes , Sequência de Carboidratos , Corantes , Ciclodextrinas/análise , DNA/administração & dosagem , Portadores de Fármacos/análise , Sistemas de Liberação de Medicamentos , Modelos Moleculares , Dados de Sequência Molecular , Sais de Tetrazólio , Tiazóis
6.
Eur J Appl Physiol ; 111(7): 1507-15, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21188410

RESUMO

The objective of this report was to analyse a potential role for FGF6 in muscle resistance to mechanical stress. Normal or regenerating muscles of FGF6 (-/-) mice versus wild-type mice were submitted to different protocols of damaging eccentric contractions (eccentric electrostimulation and intermittent downhill exercise). Then muscular structural properties were analysed by histological and immunochemistry techniques to evaluate the post-injury muscle recovery; their muscle contractile parameters (maximal tetanic force, kinetics properties and fatigue resistance) were assessed. The absence of FGF6 causes (1) a fast-to-slow myofibre type switch in adult control and regenerating Tibialis anterior (TA) muscle; (2) muscle weakness in regenerating muscles in animals submitted to eccentric exercise protocols due to aberrant extensive necrotic zones. These observations point out a crucial and unexpected role for FGF6 in muscle integrity and muscle protection against mechanical stress.


Assuntos
Fator 6 de Crescimento de Fibroblastos/fisiologia , Contração Muscular/genética , Força Muscular/genética , Estimulação Física , Estresse Mecânico , Animais , Fator 6 de Crescimento de Fibroblastos/genética , Predisposição Genética para Doença , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Contração Muscular/fisiologia , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/fisiologia , Força Muscular/fisiologia , Músculo Esquelético/metabolismo , Músculo Esquelético/fisiologia , Doenças Musculares/genética , Regeneração/genética , Regeneração/fisiologia
7.
Br J Cancer ; 100(8): 1330-5, 2009 Apr 21.
Artigo em Inglês | MEDLINE | ID: mdl-19367287

RESUMO

Recent studies have suggested that activation of the EGFR pathway leads to malignant transformation only if the p53 protein is inactivated. Therefore, we evaluated the impact of TP53 mutations on cetuximab-based chemotherapy (CT) sensitivity in combination with KRAS mutations that have been associated with cetuximab resistance. KRAS and TP53 status were assessed in tumours from 64 metastatic colorectal cancer patients treated with cetuximab-based CT and correlated to clinical response using the Fisher's exact test. Times to progression (TTPs) according to gene status were calculated using the Kaplan-Meier method and compared with log-rank test. TP53 mutations were found in 41 patients and were significantly associated with controlled disease (CD), as defined as complete response, partial response or stable disease (P=0.037) and higher TTP (20 vs 12 weeks, P=0.004). Remarkably, in the subgroup of 46 patients without KRAS mutation, but not in patients with KRAS mutation, TP53 mutations were also associated with CD (P=0.008) and higher TTP (24 vs 12 weeks, P=0.0007). This study suggests that TP53 mutations are predictive of cetuximab sensitivity, particularly in patients without KRAS mutation, and that TP53 genotyping could have a clinical interest to select patients who should benefit from cetuximab-based CT.


Assuntos
Anticorpos Monoclonais/uso terapêutico , Antineoplásicos/uso terapêutico , Neoplasias Colorretais/tratamento farmacológico , Neoplasias Colorretais/genética , Mutação , Proteína Supressora de Tumor p53/genética , Idoso , Substituição de Aminoácidos , Anticorpos Monoclonais Humanizados , Cetuximab , Neoplasias Colorretais/patologia , DNA de Neoplasias/genética , DNA de Neoplasias/isolamento & purificação , Progressão da Doença , Relação Dose-Resposta a Droga , Éxons , Feminino , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Metástase Neoplásica , Polimorfismo de Nucleotídeo Único , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas p21(ras) , Proteínas ras/genética
9.
Br J Cancer ; 96(8): 1166-9, 2007 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-17375050

RESUMO

The predictive value of KRAS mutation in metastatic colorectal cancer (MCRC) patients treated with cetuximab plus chemotherapy has recently been suggested. In our study, 59 patients with a chemotherapy-refractory MCRC treated with cetuximab plus chemotherapy were included and clinical response was evaluated according to response evaluation criteria in solid tumours (RECIST). Tumours were screened for KRAS mutations using first direct sequencing, then two sensitive methods based on SNaPshot and PCR-ligase chain reaction (LCR) assays. Clinical response was evaluated according to gene mutations using the Fisher exact test. Times to progression (TTP) were calculated using the Kaplan-Meier method and compared with log-rank test. A KRAS mutation was detected in 22 out of 59 tumours and, in six cases, was missed by sequencing analysis but detected using the SNaPshot and PCR-LCR assays. Remarkably, no KRAS mutation was found in the 12 patients with clinical response. KRAS mutation was associated with disease progression (P=0.0005) and TTP was significantly decreased in mutated KRAS patients (3 vs 5.5 months, P=0.015). Our study confirms that KRAS mutation is highly predictive of a non-response to cetuximab plus chemotherapy in MCRC and highlights the need to use sensitive molecular methods, such as SNaPshot or PCR-LCR assays, to ensure an efficient mutation detection.


Assuntos
Anticorpos Monoclonais/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Colorretais/genética , Receptores ErbB/antagonistas & inibidores , Genes ras , Mutação , Anticorpos Monoclonais Humanizados , Cetuximab , Neoplasias Colorretais/tratamento farmacológico , Humanos , Metástase Neoplásica , Reação em Cadeia da Polimerase
10.
Sante Publique ; 17(2): 211-26, 2005 Jun.
Artigo em Francês | MEDLINE | ID: mdl-16001563

RESUMO

HIV and AIDS prevention is part of the biology class curriculum in junior high and high school in both France and the Congo. The teachers must not only present the scientific knowledge but also try to incite and convince the students to adopt certain preventive behaviours in terms of their own personal conduct. This places the teachers in the domain of having a health promotion and education role. How do teachers perceive this new role? What objectives and outcome measures have they set, and what kind of educational method do they intend to use to achieve them? Based on interviews conducted in the year 2000 of 25 teachers (12 in France and 13 in Congo-Brazzaville), a profile has been defined for each teacher based on an analysis of his/her responses with regard to their role in terms of health education and more specifically in relation to AIDS prevention. A number of questions and concems emerged from this exercise, some of which were shared in common and others were clearly country-specific.


Assuntos
Síndrome da Imunodeficiência Adquirida/prevenção & controle , Biologia/educação , Comportamentos Relacionados com a Saúde , Educação de Pacientes como Assunto , Serviços de Saúde Escolar , Adolescente , Congo , Currículo , Feminino , França , Humanos , Masculino , Avaliação de Programas e Projetos de Saúde
12.
Acta Physiol Scand ; 179(1): 75-84, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12940941

RESUMO

AIM: The aim of this report is to show that eccentric exercise under well-controlled conditions is an alternative model, to chemical and mechanical analyses, and analyse the process of degeneration/regeneration in mouse soleus. METHODS: For this, mice were submitted to a single bout of eccentric exercise on a treadmill down a 14 degrees decline for 150 min and the soleus muscle was analysed at different times following exercise by histology and in situ hybridization in comparison with cardiotoxin-injured muscles. RESULTS: We analyse the regenerative process by detection of the accumulation of transcripts coding for the two myogenic regulatory factors, Myf-5 and MyoD, which are good markers of the activated satellite cells. From 24 h post-exercise (P-E), clusters of mononucleated Myf-5/MyoD-positive cells were detected. Their number increased up to 96 h P-E when young MyoD-positive myotubes with central nuclei began to appear. From 96 to 168 h P-E the number of myotubes increased, about 10-fold, the new myotubes representing 58% of the muscle cells (168 h P-E). CONCLUSION: These results show that this protocol of eccentric exercise is able to induce a drastic degeneration/regeneration process in the soleus muscle. This offers the opportunity to perform biochemical and molecular analyses of a process of regeneration without muscle environment defects. The advantages of this model are discussed in the context of fundamental and therapeutical perspectives.


Assuntos
Proteínas de Ligação a DNA , Músculo Esquelético/fisiologia , Esforço Físico/fisiologia , Regeneração , Transativadores , Animais , Proteínas Cardiotóxicas de Elapídeos , Modelos Animais de Doenças , Feminino , Camundongos , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/patologia , Fibras Musculares Esqueléticas/fisiologia , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , Proteína MyoD/metabolismo , Fator Regulador Miogênico 5 , Necrose
13.
Protein Expr Purif ; 23(1): 121-7, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11570853

RESUMO

This paper describes the overproduction and purification of the C-terminus polyhistidine-tagged outer membrane protein OprM, which is a part of the MexA-MexB-OprM active efflux system of Pseudomonas aeruginosa. Renaturation of the protein from inclusion bodies of Escherichia coli was achieved using guanidine-HCl as denaturing agent and n-octylpolyoxyethylene (C8POE) and n-octyltetraoxyethylene (C8E4) as nonionic detergents. The refolded protein was purified by ion-exchange and nickel-affinity chromatography. The final yield was 6 mg of pure histidine-tagged OprM per liter of E. coli culture. Renaturation was monitored by the effects of heating prior to SDS-PAGE, using a typical and exclusive property of outer membrane proteins. Immunoblotting revealed that the recombinant protein is addressed to the outer membrane of E. coli, after maturation by excision of its N-terminal signal sequence. Complementation of an oprM deletion mutant with the plasmid encoded histidine-tagged OprM protein restored antibiotic susceptibilities to wild-type levels, demonstrating functionality of recombinant OprM.


Assuntos
Proteínas da Membrana Bacteriana Externa/biossíntese , Proteínas de Transporte/biossíntese , Clonagem Molecular/métodos , Proteínas de Membrana Transportadoras , Renaturação Proteica , Marcadores de Afinidade , Proteínas da Membrana Bacteriana Externa/genética , Proteínas da Membrana Bacteriana Externa/isolamento & purificação , Proteínas de Transporte/genética , Proteínas de Transporte/isolamento & purificação , Membrana Celular , Escherichia coli/genética , Escherichia coli/ultraestrutura , Histidina , Temperatura Alta , Corpos de Inclusão , Dobramento de Proteína , Pseudomonas aeruginosa/química , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação
14.
J Histochem Cytochem ; 49(7): 887-99, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11410613

RESUMO

Given the importance of the myogenic regulatory factors (MRFs) for myoblast differentiation during development, the aims of this work were to clarify the spatial and temporal expression pattern of the four MRF mRNAs during soleus regeneration in mouse after cardiotoxin injury, using in situ hybridization, and to investigate the influence of innervation on the expression of each MRF during a complete degeneration/regeneration process. For this, we performed cardiotoxin injury-induced regeneration experiments on denervated soleus muscle. Myf-5, MyoD, and MRF4 mRNAs were detected in satellite cell-derived myoblasts in the first stages of muscle regeneration analyzed (2--3 days P-I). The Myf-5 transcript level dramatically decreased in young multinucleated myotubes, whereas MyoD and MRF4 transcripts were expressed persistently throughout the regeneration process. Myogenin mRNA was transiently expressed in forming myotubes. These results are discussed with regard to the potential relationships between MyoD and MRF4 in the satellite cell differentiation pathway. Muscle denervation precociously (at 8 days P-I) upregulated both the Myf-5 and the MRF4 mRNA levels, whereas the increase of both MyoD and myogenin mRNA levels was observed later, in the late stages of regeneration (30 days P-I). This significant accumulation of each differentially upregulated MRF during soleus regeneration after denervation suggests that each myogenic factor might have a distinct role in the regulatory control of muscle gene expression. This role is discussed in relation to the expression of the nerve-regulated genes, such as the nAChR subunit gene family. (J Histochem Cytochem 49:887-899, 2001)


Assuntos
Proteínas de Ligação a DNA , Músculo Esquelético/inervação , Músculo Esquelético/metabolismo , Fatores de Regulação Miogênica/metabolismo , Regeneração , Transativadores , Animais , Proteínas Cardiotóxicas de Elapídeos , Feminino , Regulação da Expressão Gênica , Hibridização In Situ , Camundongos , Denervação Muscular , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Músculo Esquelético/fisiologia , Proteína MyoD/metabolismo , Fator Regulador Miogênico 5 , Fatores de Regulação Miogênica/genética , Miogenina , RNA Mensageiro/metabolismo
17.
Mech Dev ; 94(1-2): 277-82, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10842087

RESUMO

SPOCK is prevalent in developing synaptic fields of the central nervous system (Charbonnier et al., 2000. Mech. Dev. 90, 317-321). The expression of SPOCK during neuromuscular junction (NMJ) formation was compared to agrin and acetylcholine receptor (AChR) distribution. SPOCK is detected within the myogenic masses during the early steps of embryonic development, and distributed in the cytoplasm of myotubes before coclustering with AChRs. In the adult, SPOCK is present in axons and is highly expressed by Schwann cells. SPOCK altered expression pattern after nerve lesioning, or cholinergic transmission blockade, strongly indicate that its cellular distribution at the NMJ depends on innervation.


Assuntos
Músculo Esquelético/embriologia , Junção Neuromuscular/embriologia , Junção Neuromuscular/crescimento & desenvolvimento , Proteoglicanas/genética , Proteoglicanas/metabolismo , Animais , Citoplasma/metabolismo , Regulação da Expressão Gênica no Desenvolvimento , Camundongos , Camundongos Endogâmicos , Fibras Musculares Esqueléticas/fisiologia , Proteoglicanas/imunologia , Ratos , Ratos Sprague-Dawley , Receptores Colinérgicos/metabolismo
18.
Cancer Res ; 60(11): 2760-3, 2000 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-10850409

RESUMO

Large genomic deletions within the mismatch repair MLH1 and MSH2 genes have been identified in families with the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome, and their detection represents a technical problem. To facilitate their detection, we developed a simple semiquantitative procedure based on the multiplex PCR of short fluorescent fragments. This method allowed us to confirm in HNPCC families three known deletions of MLH1 or MSH2 and to detect in 19 HNPCC families, in which analysis of mismatch repair genes using classical methods had revealed no alteration, a deletion of exon 5 and a duplication of MSH2 involving exons 9 and 10. The presence of such duplications, the frequency of which is probably underestimated, must be considered in HNPCC families in which conventional screening methods have failed to detect mutations.


Assuntos
Neoplasias Colorretais Hereditárias sem Polipose/genética , Reparo do DNA/genética , Proteínas de Ligação a DNA , Deleção de Genes , Duplicação Gênica , Proteínas de Neoplasias/genética , Proteínas Proto-Oncogênicas/genética , Proteínas Adaptadoras de Transdução de Sinal , Pareamento Incorreto de Bases/genética , Proteínas de Transporte , Éxons , Saúde da Família , Humanos , Íntrons , Modelos Genéticos , Proteína 1 Homóloga a MutL , Proteína 2 Homóloga a MutS , Proteínas Nucleares , Reação em Cadeia da Polimerase/métodos
19.
Carcinogenesis ; 21(4): 563-5, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10753186

RESUMO

Somatic mutations of the tumor suppressor gene p53 have been frequently detected in esophagal cancers, but their biological significance remains to be established. The tumor suppressor activity of p53 results in part from its ability to transactivate genes involved in the cell cycle and apoptosis, such as p21, bax and PIG3, and some p53 mutations may have a differential effect on the transactivation of these target genes. We developed yeast strains in which the activation by wild-type p53 of reporter plasmids containing p53 binding sites present within these target genes induces a change in the color of the colonies (red/white). Using these strains, we analyzed 56 esophageal cancers from patients residing in Normandy, France, a high incidence geographic area. Forty-seven tumors (84%), scored as mutant with the p21, bax and PIG3 reporter strains and in most of the cases (76%), the percentage of red colonies suggested that both p53 alleles were inactivated. Sequencing analysis allowed the identification of a p53 mutation in each positive sample, and the spectrum of mutations was in agreement with the etiological role of tobacco and alcohol. These results confirm the high frequency of biallelic p53 mutations in esophageal carcinoma and strongly suggest that their biological consequence is the complete alteration of the transactivation of genes involved in the cell cycle and apoptosis, which indicates that p53 alteration is a key event in esophagus carcinogenesis.


Assuntos
Apoptose , Neoplasias Esofágicas/genética , Regulação Neoplásica da Expressão Gênica , Genes p53 , Mutação , Ciclo Celular , Inibidor de Quinase Dependente de Ciclina p21 , Ciclinas/genética , Humanos
20.
Mech Dev ; 90(2): 317-21, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10640720

RESUMO

SPOCK is a modular proteoglycan, with homology with proteins involved in cell adhesion processes and neurogenesis. We have previously shown that SPOCK transcripts predominate in the adult mouse brain. Here, we report its expression during mouse embryonic development by in situ hybridization, and immunocytochemistry. SPOCK is actively expressed at the onset of neurogenesis during periods of neuron migration and axonal outgrowth. At a later developmental stage, its expression is particularly prevalent within developing synaptic fields. In the peripheral nervous system, SPOCK expression is also developmentally regulated particularly in dorsal root ganglion neurons.


Assuntos
Desenvolvimento Embrionário e Fetal , Proteoglicanas/genética , Animais , Expressão Gênica , Camundongos , Sistema Nervoso/embriologia , Proteoglicanas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA